Effect of NR-Salacia on post-prandial hyperglycemia: A randomized double blind, placebo-controlled, crossover study in healthy volunteers

Pharmacognosy Magazine

Volumn 9, Issue 36, 2013, Pages 344-349

  Koteshwar, Pravina ^a   Raveendra, Kadur Ramamurthy ^b   Allan, Joseph Joshua ^c   Goudar, Krishnagouda ^c   Goudar, Krishnagouda Shankargouda ^c   Agarwal, Amit ^c  

^a Institute of Clinical Research India   (India)

^b Srinivasa Diabetic Research Centre   (India)

^c Natural Remedies ^*  (India)

Author keywords

Carbohydrate rich diet; cross over; double blind placebo controlled; hypoglycemic; post prandial glucose; Salacia chinensis

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; PLACEBO; PLANT EXTRACT; SALACIA CHINENSIS EXTRACT; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ABDOMINAL DISTENSION; ADULT; ANTIDIABETIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CARBOHYDRATE DIET; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INDUCED HEADACHE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SALACIA CHINENSIS; VOMITING;

EID: 84884601004     PISSN: 09731296     EISSN: 09764062     Source Type: Journal    
DOI: 10.4103/0973-1296.117831     Document Type: Article

References (39)

1. Smyth S, Heron A. Diabetes and obesity: The twin epidemics. Nat Med 2006;12:75-80.
2. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006;368:1681-8.
3. Udani J, Hardy M, Madsen DC. Blocking carbohydrate absorption and weight loss: A clinical trial using Phase 2™ brand proprietary fractionated white bean extract. Altern Med Rev 2004;9:63-9.
4. Heacock PM, Hertzler SR, Williams JA, Wolf BW. Effects of a medical food containing an herbal alpha-glucosidase inhibitor on postprandial glycemia and insulinemia in healthy adults. J Am Diet Assoc 2005;105:65-71.
5. Maji D, Singh AK. Clinical Trial of D-400-A Herbomineral Preparation in Diabetes Mellitus. J Diab Assoc 1995;35:1-4.
6. Joshi CS, Priya ES, Venkataraman S. Hypoglycemic and antilipidperoxidative effects of a polyherbal formulation, diakyur, in experimental animal models. J Health Sci 2007;53:734-9.
7. Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TP. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nut 2007;40:163-73.
8. Bnouham M, Ziyyat A, Mekhfi H, Tahri A, Legssyer A. Medicinal plants with potential antidiabetic activity-A review of ten years of herbal medicine research (1990-2000). Int J Diabetes and Metab 2006;14:1-25.
9. Krause HP, Keup U, Puls W. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421). Digestion 1982;23:232-8.
10. Puls W, Keup U, Krause HP, Thomas G, Hoffmeister F. Glucosidase inhibition. A new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia. Naturwissenschaften 1977;64:536-7.
11. Layer P, Carlson GL, Di Magno EP. Partially purifi ed white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans. Gastroenterology 1985;88:1895-902.
12. Miwa I, Okuda J, Horie T, Nakayama M. Inhibition of intestinal ?-glucosidases and sugar absorption by fl avones. Chem Pharm Bull 1986;34:838-44.
13. Wolf BW, Weisbrode SE. Safety evaluation of an extract from Salacia oblonga. Food Chem Toxicol 2003;41:867-74.
14. Matsuda H, Murakami T, Yashiro K, Yamahara J, Yoshikawa M. Antidiabetic principles of natural medicines. IV. Aldose reductase and ?-glucosidase inhibitors from the roots of Salacia oblonga Wall. (Celastraceae): Structure of a new friedelane-type triterpene, kotalagenin 16-acetate. Chem Pharm Bull 1999;47:1725-9.
15. Naveen A. Hepatoprotective activity of ethanolic extract of root bark of Salacia chinensis. J Pharm Res 2010;3:833-4.
16. Govindaraj Y, Melanaphuru V, Agrahari V, Gupta S, Nema RK. Genotoxicity studies of magiferin isolated from Salacia chinensis Linn. Acad J Plant Sci 2009;2:199-204.
17. Jihong Y, Shaozhong L, Jingfeng S, Kobayashi M, Akaki J, Yamashita K, et al. Effects of Salacia chinensis extract on reproductive outcome in rats. Food Chem Toxicol 2011;49:57-60.
18. Hanefeld M. Pioglitazone and sulfonylureas: effectively treating type 2 diabetes. Int J Clin Pract Suppl 2007;153:20-7.
19. Johnston PS, Lebovitz HE, Coniff RF, Simonson DC, Raskin P, Munera CL. Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients. J Clin Endocrinol Metab 1998;83:1515-22.
20. Wild S, Rogli G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
21. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997;14:S1-85.
22. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-31.
23. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial. Lancet 2002;359:2072-7.
24. Chiasson JL. Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: The Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) trial. Endocr Pract 2006;12:25-30.
25. Yamagishi S, Nakamura K, Takeuchi M. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome. Med Hypotheses 2005;65:152-4.
26. Takami K, Takeda N, Nakashima K, Takami R, Hayashi M, Ozeki S, et al. Effects of dietary treatment alone or diet with voglibose or glyburide on abdominal adipose tissue and metabolic abnormalities in patients with newly diagnosed type 2 diabetes. Diabetes Care 2002;225:658-62.
27. van de Laar FA, Lucassen PL, Akkermans RP, van de Lisdonk EH, Rutten GE, van Weel C. Alpha-glucosidase inhibitors for patients with type 2 diabetes: Results from a Cochrane systematic review and meta-analysis. Diabetes Care 2005;28:154-63.
28. Yoshino K, Miyauchi Y, Kanetaka T, Takagi Y, Koga K. Anti-diabetic activity of a leaf extract prepared from Salacia reticulata in mice. Biosci Biotechnol Biochem 2009;73:1096-104.
29. Yajnik VH, Acharya HK, Vithlani MP, Yajnik NV. Effi cacy and safety of Diabecon (D-400), a herbal formuation, in diabetic patients. Indian Pract 1993;46:917-22.
30. Kumar P, Dharmalingam M, Kulkarani KS. Evaluation of clinical effi cacy of Diabecon with reference to insulin levels in diabetic patients. Med Update 2002;7:67-70.
31. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 2003;26:1277-94.
32. Sellamuthu PS, Muniappan BP, Perumal SM, Kandasamy M. Antihyperglycemic effect of mangiferin in streptozotocin induced diabetic rats. J Health Sci 2009;55:206-14.
33. Yoshikawa M, Pongpiriyadacha Y, Kishi T, Wang T, Morikawa T, Mastuda H. Biological activites of Salacia chinesis originating in Thailand: The quality evaluation guided by alpha-glucosidase inhibitory activity. Yakugaku Zasshi 2003;123:871-80.
34. Collene AL, Hertzler SR, Williams JA, Wolf BW. Effects of a nutritional supplement containing Salacia oblonga extract and insulinogenic amino acids on postprandial glycemia, insulinemia, and breath hydrogen responses in healthy adults. Nutrition 2005;21:848-54.
35. Williams JA, Choe YS, Noss MJ, Baumgartner CJ, Mustad VA. Extract of Salacia oblonga lowers acute glycemia in patients with type 2 diabetes. Am J Clin Nutr 2007;86:124-30.
36. Yoshikawa M, Nishida N, Shimoda H, Takada M, Kawahara Y, Matsuda H. Polyphenol constituents from Salacia species: quantitative analysis of Mangiferin with alpha-glucosidase and aldose reductase inhibitory activities. Yakugaku zasshi 2001;121:371-8.
37. van de Laar FA. Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes. Vasc Health Risk Manag 2008;4:1189-95.
38. Joubert PH, Venter HL, Foukaridis GN. The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism? Br J Clin Pharmacol 1990;30:391-6.
39. Hotta N, Kakuta H, Sano T, Matsumae H, Yamada H, Kitazawa S, et al. Long-term effect of acarbose on glycaemic control in non-insulin-dependent diabetes mellitus: A placebo-controlled double-blind study. Diabet Med 1993;10:134-8.